ScoreCritical care

RESP score (survival on venovenous ECMO)

Estimates hospital survival in adults with severe acute respiratory failure treated with venovenous ECMO.

Updated 31 October 2026

When to use it

Before cannulation, using pre-ECMO data, to inform prognosis and benchmark outcomes between centres.

What it needs

  • AgeOptions: 18–49 years · 50–59 years · 60 years or older
  • ImmunocompromisedYes or no
  • Mechanical ventilation before ECMOOptions: Less than 48 hours · 48 hours to 7 days · More than 7 days
  • Main acute respiratory diagnosisOptions: Viral pneumonia · Bacterial pneumonia · Asthma · Trauma or burn · Aspiration pneumonitis · Other acute respiratory diagnosis · Non-respiratory or chronic respiratory diagnosis
  • Central nervous system dysfunctionYes or no
  • Acute associated non-pulmonary infectionYes or no
  • Neuromuscular blockade before ECMOYes or no
  • Inhaled nitric oxide before ECMOYes or no
  • Bicarbonate infusion before ECMOYes or no
  • Cardiac arrest before ECMOYes or no
  • PaCO₂ before ECMOUnits: mmHg, kPa
  • Peak inspiratory pressure before ECMOUnits: cmH₂O

The points for each answer and the automatic total are in the app.

How to interpret it

RESP score
ResultInterpretation
≤ -6Class V: estimated hospital survival ≈ 18 %
-5–-2Class IV: estimated hospital survival ≈ 33 %
-1–2Class III: estimated hospital survival ≈ 57 %
3–5Class II: estimated hospital survival ≈ 76 %
≥ 6Class I: estimated hospital survival ≈ 92 %

Practical tip

It was derived in over 2300 ELSO registry patients (2000–2012); it does not apply to venoarterial ECMO or children.

3 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top